Announcing our latest investment led by Spectrum Equity and McKesson Ventures
RxVantage recently shared news of its latest investment directed by McKesson Ventures and Spectrum Equity. These two investors will be joining RxVantage’s existing investors, which include Merck Global Health Innovation Fund, Slater Technology Fund, Javelin Venture Partners, and dRx Capital. RxVantage’s goal is to promote technology that allows professionals in healthcare and life science to collaborate seamlessly, safely, and effectively. Its technology allows medical practices to get important resources, wherever and whenever they are needed. The new investment is following a time of notable growth for...